These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38663975)

  • 1. Risk stratification refinements with inclusion of haemodynamic variables at follow-up in patients with pulmonary arterial hypertension.
    Boucly A; Beurnier A; Turquier S; Jevnikar M; de Groote P; Chaouat A; Cheron C; Jaïs X; Picard F; Prévot G; Roche A; Solinas S; Cottin V; Bauer F; Montani D; Humbert M; Savale L; Sitbon O;
    Eur Respir J; 2024 Sep; 64(3):. PubMed ID: 38663975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Value of Follow-Up Hemodynamic Variables After Initial Management in Pulmonary Arterial Hypertension.
    Weatherald J; Boucly A; Chemla D; Savale L; Peng M; Jevnikar M; Jaïs X; Taniguchi Y; O'Connell C; Parent F; Sattler C; Hervé P; Simonneau G; Montani D; Humbert M; Adir Y; Sitbon O
    Circulation; 2018 Feb; 137(7):693-704. PubMed ID: 29070502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemodynamics and serial risk assessment in systemic sclerosis associated pulmonary arterial hypertension.
    Weatherald J; Boucly A; Launay D; Cottin V; Prévot G; Bourlier D; Dauphin C; Chaouat A; Savale L; Jaïs X; Jevnikar M; Traclet J; De Groote P; Simonneau G; Hachulla E; Mouthon L; Montani D; Humbert M; Sitbon O
    Eur Respir J; 2018 Oct; 52(4):. PubMed ID: 30209196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of rapid sequential combination therapy on distinct haemodynamic measures in newly diagnosed pulmonary arterial hypertension.
    Kramer T; Nattmann P; Gerhardt F; Stafiej P; Dumitrescu D; Ten Freyhaus H; Wißmüller M; Hohmann C; Baldus S; Rosenkranz S
    ESC Heart Fail; 2024 Jun; 11(3):1540-1552. PubMed ID: 38224960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison Between REVEAL Lite 2 and COMPERA 2.0 for Risk Stratification in Pulmonary Arterial Hypertension.
    Sahay S; Villasmil Hernandez N; Wang F; Wooten M; Nguyen DT; Fauvel C; Benza R; Graviss EA
    Chest; 2024 Aug; 166(2):373-387. PubMed ID: 38447640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic role of haemodynamics at follow-up in patients with pulmonary arterial hypertension: a challenge to current European Society of Cardiology/European Respiratory Society risk tools.
    Dardi F; Guarino D; Ballerini A; Bertozzi R; Donato F; Cennerazzo F; Salvi M; Nardi E; Magnani I; Manes A; Galiè N; Palazzini M
    ERJ Open Res; 2024 Jul; 10(4):. PubMed ID: 39104950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Value of Hemodynamic Measurements or Cardiac MRI in the Follow-up of Patients With Idiopathic Pulmonary Arterial Hypertension.
    van der Bruggen CE; Handoko ML; Bogaard HJ; Marcus JT; Oosterveer FPT; Meijboom LJ; Westerhof BE; Vonk Noordegraaf A; de Man FS
    Chest; 2021 Apr; 159(4):1575-1585. PubMed ID: 33197401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pragmatic approach to risk assessment in pulmonary arterial hypertension using the 2015 European Society of Cardiology/European Respiratory Society guidelines.
    Dardi F; Manes A; Guarino D; Zuffa E; De Lorenzis A; Magnani I; Rotunno M; Ballerini A; Lo Russo GV; Nardi E; Galiè N; Palazzini M
    Open Heart; 2021 Oct; 8(2):. PubMed ID: 34667092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the European Society of Cardiology/European Respiratory Society derived three- and four-strata risk stratification models in pulmonary arterial hypertension: introducing an internet-based risk stratification calculator.
    Ahmed A; Ahmed S; Kempe D; Rådegran G
    Eur Heart J Open; 2023 Mar; 3(2):oead012. PubMed ID: 36959867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simplified risk stratification for pulmonary arterial hypertension associated with connective tissue disease.
    Li X; Sun X; Huang Y; Wang Y; Yang X; Wang J; Zhang N; Gu L; Zhang M; Wang Q
    Clin Rheumatol; 2019 Dec; 38(12):3619-3626. PubMed ID: 31385084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incremental prognostic value of cardiopulmonary exercise testing and resting haemodynamics in pulmonary arterial hypertension.
    Wensel R; Francis DP; Meyer FJ; Opitz CF; Bruch L; Halank M; Winkler J; Seyfarth HJ; Gläser S; Blumberg F; Obst A; Dandel M; Hetzer R; Ewert R
    Int J Cardiol; 2013 Aug; 167(4):1193-8. PubMed ID: 22494868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mixed Venous Oxygen Saturation Is a Better Prognosticator Than Cardiac Index in Pulmonary Arterial Hypertension.
    Khirfan G; Almoushref A; Naal T; Abuhalimeh B; Dweik RA; Heresi GA; Tonelli AR
    Chest; 2020 Dec; 158(6):2546-2555. PubMed ID: 32629034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Cardiac Magnetic Resonance Imaging Thresholds for Risk Stratification in Pulmonary Arterial Hypertension.
    Lewis RA; Johns CS; Cogliano M; Capener D; Tubman E; Elliot CA; Charalampopoulos A; Sabroe I; Thompson AAR; Billings CG; Hamilton N; Baster K; Laud PJ; Hickey PM; Middleton J; Armstrong IJ; Hurdman JA; Lawrie A; Rothman AMK; Wild JM; Condliffe R; Swift AJ; Kiely DG
    Am J Respir Crit Care Med; 2020 Feb; 201(4):458-468. PubMed ID: 31647310
    [No Abstract]   [Full Text] [Related]  

  • 14. Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
    Humbert M; Farber HW; Ghofrani HA; Benza RL; Busse D; Meier C; Hoeper MM
    Eur Respir J; 2019 Jun; 53(6):. PubMed ID: 30923187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New risk model by right ventricle - pulmonary arterial coupling and inferior vena cava from echocardiography in patients with conventional low-intermediate risk pulmonary artery hypertension under targeted treatment.
    Yang L; Luo D; Huang T; Li X; Zhang C; Fei H
    Echocardiography; 2024 Jun; 41(6):e15850. PubMed ID: 38818775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Right ventricular stroke work index by echocardiography in adult patients with pulmonary arterial hypertension.
    Jumatate R; Ingvarsson A; Smith GJ; Roijer A; Ostenfeld E; Waktare J; Rådegran G; Meurling C; Werther Evaldsson A
    BMC Cardiovasc Disord; 2021 Apr; 21(1):219. PubMed ID: 33931021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Significance of Proteomics-Discovered Circulating Inflammatory Biomarkers in Patients With Pulmonary Arterial Hypertension.
    Yokokawa T; Boucherat O; Martineau S; Lemay SE; Breuils-Bonnet S; Krishna V; Kalyana-Sundaram S; Jeyaseelan J; Potus F; Bonnet S; Provencher S
    J Am Heart Assoc; 2024 Jun; 13(12):e032888. PubMed ID: 38874078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemodynamically Derived Pulmonary Artery Pulsatility Index Predicts Mortality in Pulmonary Arterial Hypertension.
    Mazimba S; Welch TS; Mwansa H; Breathett KK; Kennedy JLW; Mihalek AD; Harding WC; Mysore MM; Zhuo DX; Bilchick KC
    Heart Lung Circ; 2019 May; 28(5):752-760. PubMed ID: 29748060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of risk assessment tools in predicting hemodynamic outcome after balloon pulmonary angioplasty: a comparative analysis.
    Li X; Zhang Y; Zhao Q; Yang T; Zeng Q; Jin Q; Duan A; Huang Z; Hu M; Zhang S; Gao L; Xiong C; Luo Q; Zhao Z; Liu Z
    Postgrad Med; 2024 May; 136(4):446-455. PubMed ID: 38785198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model.
    Hoeper MM; Kramer T; Pan Z; Eichstaedt CA; Spiesshoefer J; Benjamin N; Olsson KM; Meyer K; Vizza CD; Vonk-Noordegraaf A; Distler O; Opitz C; Gibbs JSR; Delcroix M; Ghofrani HA; Huscher D; Pittrow D; Rosenkranz S; Grünig E
    Eur Respir J; 2017 Aug; 50(2):. PubMed ID: 28775047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.